Unilever divests Opus Health Care to Segulah
Unilever Sverige has agreed to divest Opus Health Care to Segulah IV, L.P.
Opus Health Care is a market leader in Swedish health care with a variety of disinfectant and skin care products marketed primarily to hospitals, public health care providers, and office supply wholesalers in the Nordic region. The transaction also includes a new distribution agreement between Unilever and Opus Health Care covering the sales and marketing of dental care, detergent and hygiene products.
Unilever was advised by Mannheimer Swartling in the transaction. The firm’s team included Isabella Ramsay, Erica Wiking Häger, Sophie Ahlberg and Florian Geissler.